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he last decade has seen striking progress in our
understanding of the epidemiology of schizophrenia.
Some traditional beliefs have been confirmed, but oth-
ers have been swept away, while recent data have impli-
cated new risk factors for the disorder and have changed
the way we conceptualize it.
Descriptive epidemiology
Lifetime prevalence
Schizophrenia affects just under 1% of the population at
some point in their life. Perhaps the most comprehensive
study to demonstrate this comes from Finland; Perala et
al estimated lifetime prevalence, according to DSM-IV
criteria, at 0.87% for schizophrenia, and 0.32% for
schizoaffective disorder.
1
Incidence
For many years the curious view held sway that the inci-
dence of schizophrenia was constant both geographically
and temporally.
2 However, we now know that this is not
so.
3,4A systematic review
5 showed that rates for the inci-
dence of schizophrenia ranged from 7.7 to 43.0 per
100 000, a fivefold difference. There are fewer data con-
cerning long-term trends, but it has been demonstrated
that the operationally defined incidence of schizophre-
nia in South London doubled between 1965 and 1997.
6
Age of onset
Kirkbride et al assessed the incidence of psychosis in
three English cities as part of the large AESOP
(Aetiology and Ethnicity of Schizophrenia and Other
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Major advances have been made in our understanding of
the epidemiology of schizophrenia. We now know that
the disorder is more common and severe in young men,
and that the incidence varies geographically and tempo-
rally. Risk factors have been elucidated; biological risks
include a family history of the disorder, advanced pater-
nal age, obstetric complications, and abuse of drugs such
as stimulants and cannabis. In addition, recent research
has also identified social risk factors such as being born
and brought up in a city, migration, and certain types of
childhood adversity such as physical abuse and bullying,
as well as social isolation and adverse events in adult life.
Current research is focussing on the significance of minor
psychotic symptoms in the general population, gene-envi-
ronmental interaction, and how risk factors impact on
pathogenesis; perhaps all risk factors ultimately impact
on striatal dopamine as the final common pathway. 
© 2010, LLS SAS Dialogues Clin Neurosci. 2010;12:305-315.
PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 305Psychoses) study. Figure 1 shows the age-specific inci-
dence rates for psychosis as a whole and for the main
diagnostic types. It can be seen (Figure 1c) that the peak
incidence for schizophrenia in males was between 20 and
24 years, but 29 to 32 years in females; the latter showed
a flatter curve with more cases presenting in later life.
7
Thus, the AESOP study confirms previous evidence of
an earlier age of schizophrenia onset in males. One of
the most detailed studies of gender differences investi-
gated 477 first-contact cases with schizophrenia includ-
ing those presenting in later life. Though the mean age
of onset was therefore later, males still had an earlier
mean onset of illness than females (31.2 vs 41.1 years).
8
Castle et al also showed that while the incidence was rel-
atively equal in the two sexes for mild schizophrenia, as
the diagnostic criteria were narrowed so there emerged
an excess of males.
8 Other studies confirm that narrowly
defined schizophrenia tends to be more common (risk
ratio 1.4:1), and the illness tends to be more severe, in
men.
3,7,9,10The earlier age of onset in men has been attrib-
uted to the male brain’s greater susceptibility to neu-
rodevelopmental disorders,
11 while the excess in women
in the postmenopausal period could be secondary to loss
of the antidopaminergic action of estrogens.
12
Mortality
People with schizophrenia have, on average, a shorter
life than the rest of the population. McGrath et al, who
carried out a systematic review of mortality studies,
reported that the standardized mortality ratio (SMR)
was 2.6, with suicide and cardiovascular disease the
major contributors. Sadly, they found that the SMR has
been rising over recent decades.
3
Risk factors
Risk factors for schizophrenia may be crudely divided
into biological and social. 
Biological risks
Genetics
The most widely replicated risk factor for schizophrenia
is a family history of the disorder in a first-degree rela-
tive.
13Twin and adoption studies have shown that this is
largely due to genetic factors rather than family envi-
ronment.
14,15,16 Assuming a model in which genes and
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Figure 1. Incidence of psychosis in the AESOP Study.
Reproduced from ref 7: Kirkbride JB, Fearon P, Morgan C, et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings
from the 3-center Aesop study. Arch Gen Psychiatry. 2006;63:250-258. Copyright © 2006 American Medical Association
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PAGES_DCNS 46_5.qxd:DCNS#45  9/09/10  9:39  Page 306environmental factors act additively, the heritability of
schizophrenia can be calculated to be between 66% and
83%.
14 Current thinking implicates a large number of
common genes of very small effect plus rarer variants
such as copy number variations. However, as genetics is
discussed in detail elsewhere in this issue, we will not
consider this topic further here.
Parental age 
In recent years, there has been a renewed interest in
Edward Hare’s observation that advanced paternal age
is a risk factor for schizophrenia in the offspring.
17
Malaspina et al collected paternal birth data for 638 indi-
viduals with schizophrenia in Israel and reported that
the risk rose from 1/141 among those whose fathers were
less than 25 years at their birth to 1/47 for those whose
fathers were 50 to 54 years (Figure 2).
18
Torrey et al conducted a meta-analysis of 10 studies of
the paternal age effect and confirmed that risk of schiz-
ophrenia rose with increased paternal age.
19 There has
been much argument as to whether these findings are
due to biological or psychosocial factors. For instance,
older fathers could produce a less favorable psychosocial
environment for their children.
20 However, the offspring
of older fathers show subtle cognitive impairments. This,
together with the fact that autism is also associated with
increased paternal age, and that both it and schizophre-
nia show an excess of copy number variations, has raised
the possibility of mutations occurring during the repeated
mitosis in the progenitor sperm cells as men age.
19,21,22
Pre- and perinatal events
Obstetric complications
Numerous studies have reported an excess of pregnancy
and birth complications, collectively termed “obstetric
complications” (OCs) in schizophrenic patients.
23-29
Cannon et al conducted a meta-analysis of population-
based studies examining the relationship between OCs
and later development of psychosis.
30They found signif-
icant associations with schizophrenia for ten individual
complications, which they grouped into three categories:
(i) complications of pregnancy (bleeding, pre-eclampsia,
diabetes, rhesus compatibility); (ii) abnormal fetal
growth and development (low birth weight, congenital
malformations, small head circumference); (iii) compli-
cations of delivery (asphyxia, uterine atony, emergency
cesarean section).
Season of birth
One of the most consistently replicated epidemiological
features of schizophrenia is the small but significant
excess of winter-spring births found in the Northern
hemisphere (about 7% to 10%); patterns in the
Southern hemisphere are less clear.
31 Various theories
have been put forward to explain this stubborn associa-
tion; the most widely accepted postulates a teratogenic
agent,
32 or dietary deficiency, which impairs fetal brain
development. 
Considerable effort has been put into establishing
whether the winter-spring birth excess could be due to
exposure to influenza during fetal life
33 but the results
remain inconsistent. It has been found that the offspring
exposed to prenatal maternal genital and reproductive
infections were five times more likely to develop schiz-
ophrenia spectrum disorders than those who were not.
34
Prenatal exposure to toxoplasmosis and to herpes sim-
plex type 2 have also been blamed. In utero exposure to
maternal malnutrition,
35 maternal diabetes,
30 smoking,
36
and rhesus incompatibility,
37 have also been considered.
As yet none of these exposures to infectious or nonin-
fectious agents can be taken as proven. 
Hearing impairment increases the risk for psychosis.
38
The underlying mechanism could be sensory depriva-
tion
39 or social isolation and defeat
40 but hearing impair-
ment and psychosis may be due to a common cause such
as exposure to prenatal infections such as rubella.
41
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Figure 2. Incidence of schizophrenia by paternal age.
Reproduced from ref 18: Malaspina D, Harlap S, Fennig S, et al.
Advancing paternal age and the risk of schizophrenia. Arch Gen
Psychiatry. 2001;58:361-367. Copyright © 2001 American Medical
Association
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Stimulants
The capacity of psychostimulants to produce psychotic
symptoms is well known.
42,43 Since the 1990s, metham-
phetamine abuse and the consequent psychosis has
spread from Japan, Thailand, and Taiwan to California,
and then eastwards across the USA. Both amphetamine
and methamphetamine produce a picture almost identi-
cal to that of paranoid schizophrenia.
44,45
Cannabis
Recently much more attention has been paid to the rela-
tionship between cannabis and psychosis. Initially it was
widely believed that schizophrenic patients took
cannabis as “self-treatment” either to alleviate negative
or affective symptoms, or to counteract the dysphoric
side effects of antipsychotics.
46,47 However, acute inges-
tion of cannabis or its active ingredient tetrahydrocan-
abinol (THC) was found to precipitate acute psychotic
episodes in experimental studies,
48,49 and continuing use
of cannabis is known to exacerbate existing psychotic ill-
ness.
50
Andreasson et al followed up 45 570 conscripts into the
Swedish army; those who abused cannabis at 18 years
were more likely to be admitted to hospital with schizo-
phrenia over the next decade and a half. There was a
dose-response relationship such that the more cannabis
consumed the greater was the likelihood of schizophre-
nia.
51
For 15 years there was no attempt to replicate the
Swedish Army study. However, since 2002 replications
have come thick and fast,
52-54 the most recent being that
by McGrath et al.
55 Table I summarizes the main stud-
ies.
The risk appears to be greater in those with a family his-
tory of psychosis or a psychosis-prone personality,
56
those who start use early,
57,58 and the longer and more
frequently cannabis is used. Di Forti et al showed that
the risk is especially increased in those who use high
potency varieties of cannabis such as sinsemilla or skunk
(which contain up to 18% THC).
59The exact mechanism
whereby cannabis increases risk remains unclear,
60 but it
is known to have an effect on dopamine.
61
Social risk
For the last quarter of the 20th century, etiological
research interest in social factors in psychosis was virtu-
ally absent. However, from the late 1990s evidence has
grown that social factors play an important role in the
aetiology of schizophrenia. 
Urban residence
Schizophrenia is over-represented in the most deprived
sections of the population.
62-65 In 1939 it was reported
that there were higher admission rates for schizophrenia
in the poorer central areas of Chicago compared with
the suburbs.
62This pattern was consistently confirmed in
other large cities in the USA and Europe, most recently
in Ireland.
66
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Country in which the study was conducted Study design Number of  Follow-up Odds ratio (95% CI)
participants (adjusted risk)
United States (Tien & Anthony, 1990) Population based 4494 NA 2.4 (1.2-7.1)
Sweden (Andreasson et al, 1987; Zammit et al, 2002) Conscript cohort 50 053 15 years 2.3 (1.0-5.3)
27 years 3.1 (1.7-5.5)
The Netherlands (NEMESIS) (van Os et al, 2002) Population based 4045 3 years 2.8 (1.2-6.5)
Israel (Weiser, Knobler, Noy, & Kaplan, 2002) Population based 9724 4 -15 years 2.0 (1.3-3.1)
New Zealand (Dunedin) (Arseneault et al, 2002) Birth cohort 1034 15 years 3.1 (0.7-13.3)
New Zealand (Christchurch) (Fergusson et al, 2003) Birth cohort 1265 3 years 1.8 ( 1.2-2.6)
The Netherlands (Ferdinand et al, 2005) Population based 1580 14 years 2.8 (1.8-4.4)
Germany (EDSP) (Henquet et al, 2005) Population based 2437 4 years 1.7 (1.1-1.5)
United Kingdom (Wiles et al, 2006) Population based 8580 18 months  1.5 (0.5-3.9)
Greece (Stefanis et al 2004) Birth Cohort 3500 NA 4.3 (1.0-17.9)
Australia (McGrath et al, 2010) Birth Cohort 3800 21 years 2.2 (1.1-4.5)
Table I. Epidemiological studies examining cannabis use and risk of psychosis.
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preschizophrenic individuals drifting into the deprived
inner cities. However, studies from Sweden and the
Netherlands have shown that the incidence of schizo-
phrenia is greater among those born or brought up in
urban areas.
67,68 Pedersen and Mortensen demonstrated
that in Denmark, the larger the town and the longer the
individual has lived in a town, the greater the risk.
69
The AESOP study, discussed above, demonstrated that
the incidence of schizophrenia in South London was
double that in Nottingham and Bristol,
7 and that even
within South London there were wide variations in the
rates
70; the highest rates were found in the areas with
least social cohesion; this last finding echoes the original
findings of Faris and Dunham who suggested that social
isolation in socially disorganized parts of the city could
increase the risk of schizophrenia.
62
Migration
An increased risk of schizophrenia has been demon-
strated among Surinamese migrants in the Netherlands,
71
African refugees in Sweden,
72 Greek migrants to
Belgium,
73 and Scandinavian migrants to Denmark.
74 A
systematic review confirmed a high incidence of schizo-
phrenia among many migrants and ethnic minority
groups, and especially black migrants to European coun-
tries.
4
The AESOP study confirmed that all ethnic minority
groups in England are at increased risk for schizophre-
nia, but that African-Caribbeans and black Africans
show an especially high risk with a ninefold and sixfold
increase in the incidence respectively compared with
white Britons.
75 Many previous studies in the UK have
reported similar findings.
76-82 This excess is not a conse-
quence of misdiagnosis.
83-85 Furthermore, African-
Caribbeans do not show an increased risk of psychosis
in the West Indies,
86-88 indicating that genes alone cannot
explain the findings. Hutchinson et al showed that
among the siblings of Caribbean patients in the UK, the
risk was much lower in those sibs mostly living in the
West Indies compared with those mostly living in the
UK.
89This implies some environmental factor operating
in the UK but not in the West Indies.
Boydell et al demonstrated that as the proportion of
non-white ethnic minorities in a given neighbourhood in
London decreases, the incidence of schizophrenia in this
minority increases.
6,90The finding was subsequently repli-
cated in the Netherlands, and suggests an ameliorating
effect of social support or of decreased exposure to
adversities such as racial discrimination, in areas with
relatively high proportions of ethnic minorities.
91
Childhood adversity
Parental loss or separation
It has been noted that permanent separation from, or
death of, one or both parents was associated with a more
than threefold increased risk of schizophrenia (but not
bipolar disorder).
92 Similarly, it was observed in the
AESOP study that psychotic cases were three times
more likely than controls to have experienced a long-
term separation from one or both parents and to have
had a parent die before the age of 16.
93
Child abuse
Of course, parental separation and loss are associated
with a range of adverse early experiences, including fam-
ily conflict, socioeconomic disadvantage, and neglect and
abuse.
94 Evidence is emerging that childhood physical
abuse may increase risk of later psychosis, but whether
childhood sexual abuse is particularly culpable is con-
tentious.
95
Bullying
The association between bullying and severe mental
health problems, including self-harm, violent behavior,
and psychotic symptoms has attracted recent attention.
96
In one study, the risk of psychotic symptoms was
increased twofold among victims of bullying at ages 8
and/or 10 years, independent of other prior psy-
chopathology, family adversity, or child's IQ, and was
stronger for chronic or severe victimization.
97
Adult adversity
Life events
Many studies have reported an excess of stressful life
events before relapse of schizophrenic illness.
98-101 The
smaller number of studies of first-episode psychosis have
also shown an increased rate of life events prior to the
onset of illness.
102 There is some evidence that intrusive
Epidemiology of schizophrenia - Stilo and Murray Dialogues in Clinical Neuroscience - Vol 12 . No. 3 . 2010
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cially likely to preceed psychosis. 
Social isolation
Those with long-standing psychotic disorders experience
very high rates of unemployment,
103 more often live
alone,
104 and fail to establish long-term relationships,
105
the consequence being social isolation and exclusion.
106
Marwaha and Johnson, reviewing studies of first-episode
psychosis,
107 noted rates of employment at >40%; other
studies report similar findings.
108,109 Furthermore, in a
study using Danish national data, it was found that, com-
pared with controls, those who subsequently developed
schizophrenia were more frequently unemployed and
living alone for as long as 19 years before first hospital
admission.
110 Morgan et al compared the prevalence of a
number of indicators of adult social disadvantage and
isolation in first-episode psychotic cases and controls in
the AESOP study. All current and long-term indicators
(eg, unemployment, living alone, social housing) were
associated with an increased odds of psychosis.
111
It is uncertain whether the association between social
disadvantage and psychosis is a consequence of the
developing disorder itself, or a contributory cause of the
illness. Possibly urban living may impact on risk by iso-
lating individuals, a process compounded for those
whose social development is disrupted by frequent
moves, leading to a loss of potentially protective factors,
such as social supports. In line with such reasoning, the
number of changes of school during adolescence has
been associated with an increased risk of psychosis in
Denmark.
69
Recent conceptual developments
Psychotic symptoms in the general population
Schizophrenia was originally conceived as a disease (or
diseases) qualitatively different from the normal state.
However, minor psychotic symptoms are reported by a
surprising number of people in the general population.
112
Furthermore, the factors associated with these minor
psychotic symptoms are the same as those associated
with risk for schizophrenia; youth, male sex, poor edu-
cation, unemployment, membership of an ethnic minor-
ity, and cannabis use.
113 Thus, migrant groups with high
rates of schizophrenia, such as African-Caribbean peo-
ple living in the UK,
80,114 also show higher rates of minor
psychosis-like phenomena.
115,116
Many medical disorders such as hypertension or anemia
are considered as occupying the extreme end of a con-
tinuum; a disease threshold is imposed (eg, a diastolic
BP of 90 mm Hg) at a point beyond which intervention
is beneficial. Such a continuum view means that it is use-
ful not only to study individuals with the established dis-
ease, but also to examine what factors propel individu-
als along the continuum towards the threshold. Thus, the
NEMESIS follow-up study in the Netherlands demon-
strated that individuals from the general population who
report childhood abuse are at increased risk of devel-
oping both minor psychotic symptoms and psychotic dis-
order.
117
Gene-environment interaction 
Research has begun to focus on the possibility of gene-
environmental interaction whereby genes influence risk
of disorder only in the presence of a particular environ-
mental factor or vice versa.
118 One report suggested an
interaction between obstetric complications and several
genes involved in hypoxia,
119 while it has been suggested
that cannabis may increase the risk of psychosis, partic-
ularly in those with the val/val genotype at the COMT
locus.
120 Neither of these reports have yet been repli-
cated.
We noted earlier that heritability estimates for schizo-
phrenia range up to 83%. However, it may be that such
calculations from twin studies inflate the apparent role
of genes since gene x common environment interactions
are subsumed in the heritability figure. The fact that
many of the environmental risk factors that operate
upon schizophrenia are common to both twins in a pair
(eg, urban living, migration) could be one reason for the
relative failure of molecular genetics to identify suscep-
tibility genes of large effect for the condition.
Integrating epidemiology with pathogenesis—do all
roads lead to dopamine?
In summary, the epidemiological evidence suggests that
schizophrenia is a multifactorial disorder in which genes
interact with each other and with environmental factors
to push individuals over a threshold into expression of
the disorder.
121 The environmental risk factors operate
at various stages of life
122 but until till now there has been
Translational research
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little attempt to relate them to what we know of patho-
genesis. This is unfortunate since in many medical dis-
orders, epidemiology is integrated with etiology and
pathogenesis; for example, the risk factors for myocar-
dial infarction are known to facilitate the development
of atheroma in the coronary arteries. Such integration
has not yet happened in schizophrenia research.
However, there is much evidence that dysregulation of
striatal dopamine is the final common pathway under-
lying positive psychotic symptoms. One unifying view is
therefore that ultimately all risk factors for schizophre-
nia impact on the dopamine system.
123 Such a view is
schematically portrayed in Figure 3.
124
Here, dopamine dysregulation appears as the final step
in a complex developmental cascade that starts early in
life and ends with the onset of full-blown psychosis. Thus
stimulant drugs are known to increase synaptic
dopamine while animal studies show that isolation rear-
ing is associated with an increase in basal dopamine lev-
els.
125 There is much evidence that stress is associated
with hyperactivity of the HPA axis, and in turn high cor-
tisol is known to impact on the dopamine system.
Conclusion
The two major theories of schizophrenia, the neurode-
velopmental and the dopamine hypotheses, have hith-
erto been largely distinct and indeed independent of
much of the epidemiological evidence concerning risk
factors for the condition. However, these theories are
now beginning to be integrated through the growing evi-
dence that the major developmental risk factors for
schizophrenia appear to act by facilitating dopamine
dysregulation; this latter appears to be the final common
pathway underlying psychosis. The challenge is now to
delineate the exact chain of pathogenic mechanisms
which connect such risk factors to dopamine dysregu-
lation.  ❏
Figure 3. Developmental cascade towards schizophrenia. CNV, copy number variant; HPA, hypothalamic-pituitary-adrenal
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La epidemiología de la esquizofrenia: 
reemplazar el dogma con el conocimiento
Se han realizado importantes avances en nuestra
comprensión acerca de la epidemiología de la
esquizofrenia. Actualmente se sabe que el tras-
torno es más común y grave entre los hombres
jóvenes y que la incidencia varía geográfica y tem-
poralmente. Se han aclarado los factores de riesgo;
los riesgos biológicos incluyen una historia familiar
de la enfermedad, avanzada edad paterna, com-
plicaciones obstétricas y abuso de drogas como los
estimulantes y el cannabis. Además, la investiga-
ción reciente también ha identificado factores de
riesgo sociales como el haber nacido y haberse
criado en una ciudad, la migración y ciertos tipos
de adversidad infantil como el abuso físico y el
bullying, al igual que el aislamiento social y situa-
ciones adversas en la vida adulta. La investigación
actual está orientada hacia los síntomas psicóticos
menores en la población general, la interacción
genes-ambiente y cómo los factores de riesgo
impactan en la patogénesis; considerando que qui-
zás todos los factores de riesgo finalmente impac-
tan en la dopamina estriatal como la vía final
común. 
Épidémiologie de la schizophrénie : 
remplacer le dogme par la connaissance
Notre compréhension de l’épidémiologie de la schi-
zophrénie a fait d’énormes progrès. Nous savons
maintenant que la maladie est plus courante et plus
sévère chez les hommes jeunes et que l'incidence de
la maladie varie géographiquement et chronologi-
quement. Les facteurs de risque ont été identifiés ;
les risques biologiques comprennent des antécé-
dents familiaux de la maladie, un âge paternel
élevé, des complications obstétricales et la consom-
mation excessive de drogues comme les stimulants
et le cannabis. De plus, la recherche récente a éga-
lement identifié des facteurs de risque sociaux
comme le fait d’être né et d’avoir été élevé dans une
ville, l’immigration et certains types d’enfance mal-
heureuse comme la maltraitance physique et les bri-
mades, ainsi que l’isolation sociale et les événements
négatifs au cours de la vie adulte. La recherche
actuelle se concentre sur la signification de symp-
tômes psychotiques mineurs dans la population
générale, l’interaction gène-environnement et la
façon dont les facteurs de risque influent sur la
pathogenèse ; tous les facteurs de risque agissent
peut-être en fin de compte sur la dopamine stria-
tale, qui serait la voie finale commune. 
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